跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) eye drops - TGA Drug Approval Details
Approvals
/
TGA
/
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) eye drops
Approved
STANDARD
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) eye drops
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
1e9c151a7cdf542b
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
1e9c151a7cdf542b
Product Name
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) eye drops
Artg Id
42899
Artg Name
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) eye drops bottle
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
1993-11-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c730dc87c9bdcc77e76801f5afcb36ff.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/0f36630fbde662de2b656d014e54d7ba.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
1e9c151a7cdf542b
Type
Standard
Back to TGA Approvals
